# An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

> **NCT06257277** · — · COMPLETED · sponsor: **Bayer** · enrollment: 150 (actual)

## Conditions studied

- Contrast Enhancement in Magnetic Resonance Imaging

## Interventions

- **DRUG:** GBCAs

## Key facts

- **NCT ID:** NCT06257277
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-08
- **Primary completion:** 2025-01-29
- **Final completion:** 2025-05-26
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06257277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06257277, "An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06257277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*